AR071530A1 - Derivados de tienopiridonas como activadores de proteina quinasa activa-dos por amp (ampk) - Google Patents
Derivados de tienopiridonas como activadores de proteina quinasa activa-dos por amp (ampk)Info
- Publication number
- AR071530A1 AR071530A1 ARP090101562A ARP090101562A AR071530A1 AR 071530 A1 AR071530 A1 AR 071530A1 AR P090101562 A ARP090101562 A AR P090101562A AR P090101562 A ARP090101562 A AR P090101562A AR 071530 A1 AR071530 A1 AR 071530A1
- Authority
- AR
- Argentina
- Prior art keywords
- denotes
- het
- formula
- hal
- atoms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epidemiology (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La invencion se refiere a compuestos de la formula (1) en donde R1 denota H, A, OA, OH, Hal, NO2, COOA, COOH, CHO, COA, CONH2, CONHA, CONA2, CN, SO2A, SO2NH2, Ar o Het, R2 denota Ar o Het, B1 denota Ar-diílo o Het-diílo, B2 denota Ar o Het, Ar denota fenilo, naftilo, cada uno de los cuales no está sustituido o está mono-, di-, tri-, tetra- o pentasustituido con A, Hal, OA, OH, CHO, COA, NH2, NHA, NA2, NO2, COOA, COOH, CONH2, CONA, CONA2, SO2A, CN, C(=NH)NH2, C(=NH)NHOH y/o Het, Het denota un heterociclo insaturado o aromático mono- o bicíclico que tiene de 1 a 4 átomos de N, O y/o S, que puede estar mono-, di- o trisustituido con Hal, A, OA, OH, CHO, COA, COOH, COOA, CN, NO2, NH2, NHA, NA2, CONH2, CONHA y/o CONA2, A denota alquilo no ramificado o ramificado que tiene 1-10 átomos de C, en los que 1-7 átomos de H pueden estar reemplazados por OH, F, Cl y/o Br, o denota cicloalquilo que tiene 3-7 átomos de C, Hal denota F, Cl, Br o I, y sus derivados, sales, solvatos y estereoisomeros farmacéuticamente aceptables, incluyendo sus mezclas en todas las proporciones. Incluyendo sus composiciones farmacéuticas y su uso en el tratamiento y/o la prevencion de enfermedades y trastornos modulados por agonistas de AMP. La invencion también se refiere a intermediarios y a un método de preparacion de compuestos de la formula (1). Reivindicacion 12: Un compuesto de la formula (2) para preparar un compuesto de la formula 1 en donde R1, R2, B1 tienen los significados indicados en la reivindicacion 1, y X es un átomo de halogeno, y sus sales. Reivindicacion 13: Un compuesto de la formula (3) para preparar un compuesto de la formula 2 en donde R1, R2, B1 tienen los significados indicados en la reivindicacion 1, X es un átomo de halogeno, y ALK denota alquilo C1-6 y sus sales.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08290423 | 2008-05-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR071530A1 true AR071530A1 (es) | 2010-06-23 |
Family
ID=40756916
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP090101562A AR071530A1 (es) | 2008-05-05 | 2009-04-30 | Derivados de tienopiridonas como activadores de proteina quinasa activa-dos por amp (ampk) |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US8604202B2 (es) |
| EP (1) | EP2280952B1 (es) |
| JP (1) | JP5536757B2 (es) |
| KR (2) | KR20160038065A (es) |
| CN (1) | CN102015676B (es) |
| AR (1) | AR071530A1 (es) |
| AU (1) | AU2009243811B2 (es) |
| BR (1) | BRPI0910832B8 (es) |
| CA (1) | CA2723429C (es) |
| CO (1) | CO6331304A2 (es) |
| CY (1) | CY1113112T1 (es) |
| DK (1) | DK2280952T3 (es) |
| EA (1) | EA020773B1 (es) |
| EC (1) | ECSP10010654A (es) |
| ES (1) | ES2388485T3 (es) |
| HK (1) | HK1156313A1 (es) |
| HR (1) | HRP20120549T1 (es) |
| IL (1) | IL208988A (es) |
| MX (1) | MX2010011916A (es) |
| MY (1) | MY160357A (es) |
| NZ (1) | NZ589690A (es) |
| PL (1) | PL2280952T3 (es) |
| PT (1) | PT2280952E (es) |
| SI (1) | SI2280952T1 (es) |
| UA (1) | UA103617C2 (es) |
| WO (1) | WO2009135580A1 (es) |
| ZA (1) | ZA201008722B (es) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
| WO2011121109A1 (en) | 2010-04-02 | 2011-10-06 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and compositions comprising ampk activator (metformin/troglitazone) for the treatment of myotonic dystrophy type 1 (dm1) |
| US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
| TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
| TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
| BR112013005072B1 (pt) | 2010-09-01 | 2018-09-25 | Bayer Intelectual Property Gmbh | compostos de cetosultama ou dicetopiridina, composição herbicida compreendendo os mesmos, método para controlar plantas indesejadas e usos dos compostos ou da composição |
| KR101624020B1 (ko) * | 2011-03-07 | 2016-05-24 | 글락소스미스클라인 엘엘씨 | 퀴놀리논 유도체 |
| WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| EP2760862B1 (en) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| US8889730B2 (en) | 2012-04-10 | 2014-11-18 | Pfizer Inc. | Indole and indazole compounds that activate AMPK |
| EP2679591A1 (en) * | 2012-06-29 | 2014-01-01 | Poxel | Thienopyridone derivatives useful as activators of AMPK |
| CA2905242C (en) | 2013-03-15 | 2016-11-29 | Pfizer Inc. | Indole compounds that activate ampk |
| WO2015103480A1 (en) | 2014-01-02 | 2015-07-09 | Massachusetts Eye & Ear Infirmary | Treating ocular neovascularization |
| WO2015114663A1 (en) | 2014-01-30 | 2015-08-06 | Council Of Scientific & Industrial Research | Novel thieno [2,3-d]pyrimidin-4(3h)-one compounds with antimycobacterial properties |
| EP3310355B1 (en) * | 2015-06-16 | 2020-11-11 | University of Virginia Patent Foundation | Ptp4a3 inhibitor for the treatment of cancer |
| SI3322711T1 (sl) | 2015-06-25 | 2021-08-31 | University Health Network | Zaviralci HPK1 in postopek njihove uporabe |
| US20190054096A1 (en) | 2015-09-30 | 2019-02-21 | Instituto De Medicina Molecular | Methods for attenuating parasite virulence |
| US11584755B2 (en) | 2017-09-26 | 2023-02-21 | Ideaya Biosciences, Inc. | Dihydrothieno[3,2-b]pyridine compounds |
| WO2019106087A1 (en) * | 2017-11-29 | 2019-06-06 | Syddansk Universitet | Ampk inhibitors |
| AU2021275038A1 (en) | 2020-05-19 | 2022-12-22 | Kallyope, Inc. | AMPK activators |
| JP2023531726A (ja) | 2020-06-26 | 2023-07-25 | キャリーオペ，インク． | Ａｍｐｋアクチベーター |
| CN116322663A (zh) | 2020-09-30 | 2023-06-23 | 比奥维拉迪维治疗股份有限公司 | Ampk激活剂及其使用方法 |
| WO2022106892A1 (en) | 2020-11-17 | 2022-05-27 | Instituto De Medicina Molecular | Anti-malarial compounds |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8627698D0 (en) * | 1986-11-20 | 1986-12-17 | Boots Co Plc | Therapeutic agents |
| DE4444815A1 (de) * | 1994-12-15 | 1996-06-20 | Merck Patent Gmbh | Thienopyridone |
| AR040123A1 (es) * | 2002-05-31 | 2005-03-16 | Upjohn Co | Compuestos tiofeno, antihelminticos e insecticidas |
| US7119205B2 (en) * | 2003-05-16 | 2006-10-10 | Abbott Laboratories | Thienopyridones as AMPK activators for the treatment of diabetes and obesity |
| WO2006093518A2 (en) * | 2004-06-25 | 2006-09-08 | Apath, Llc | Thienyl compounds for treating virus-related conditions |
| US7563813B2 (en) * | 2005-05-13 | 2009-07-21 | Wyeth | Iminothiazolidinone derivatives as SFRP-1 antagonists |
| EP1754483A1 (en) * | 2005-08-18 | 2007-02-21 | Merck Sante | Use of thienopyridone derivatives as AMPK activators and pharmaceutical compositions containing them |
| JP2009520015A (ja) | 2005-12-20 | 2009-05-21 | リヒター ゲデオン ニュルト | 新規な化合物 |
| NZ589136A (en) * | 2008-04-11 | 2012-06-29 | Merck Patent Gmbh | Thienopyridone derivatives as amp-activated protein kinase (ampk) activators |
-
2009
- 2009-04-08 JP JP2011507805A patent/JP5536757B2/ja not_active Expired - Fee Related
- 2009-04-08 NZ NZ589690A patent/NZ589690A/en not_active IP Right Cessation
- 2009-04-08 KR KR1020167007434A patent/KR20160038065A/ko not_active Ceased
- 2009-04-08 MY MYPI2010005160A patent/MY160357A/en unknown
- 2009-04-08 WO PCT/EP2009/002606 patent/WO2009135580A1/en active Application Filing
- 2009-04-08 MX MX2010011916A patent/MX2010011916A/es active IP Right Grant
- 2009-04-08 EP EP09741799A patent/EP2280952B1/en active Active
- 2009-04-08 EA EA201001733A patent/EA020773B1/ru not_active IP Right Cessation
- 2009-04-08 CN CN200980116120.5A patent/CN102015676B/zh not_active Expired - Fee Related
- 2009-04-08 BR BRPI0910832A patent/BRPI0910832B8/pt not_active IP Right Cessation
- 2009-04-08 KR KR1020107027208A patent/KR101648593B1/ko active Active
- 2009-04-08 PL PL09741799T patent/PL2280952T3/pl unknown
- 2009-04-08 SI SI200930319T patent/SI2280952T1/sl unknown
- 2009-04-08 ES ES09741799T patent/ES2388485T3/es active Active
- 2009-04-08 AU AU2009243811A patent/AU2009243811B2/en not_active Ceased
- 2009-04-08 CA CA2723429A patent/CA2723429C/en active Active
- 2009-04-08 UA UAA201014384A patent/UA103617C2/ru unknown
- 2009-04-08 DK DK09741799.2T patent/DK2280952T3/da active
- 2009-04-08 PT PT09741799T patent/PT2280952E/pt unknown
- 2009-04-08 US US12/991,028 patent/US8604202B2/en active Active
- 2009-04-30 AR ARP090101562A patent/AR071530A1/es active IP Right Grant
-
2010
- 2010-10-28 IL IL208988A patent/IL208988A/en active IP Right Grant
- 2010-10-28 CO CO10134194A patent/CO6331304A2/es active IP Right Grant
- 2010-12-02 EC EC2010010654A patent/ECSP10010654A/es unknown
- 2010-12-03 ZA ZA2010/08722A patent/ZA201008722B/en unknown
-
2011
- 2011-10-06 HK HK11110571.3A patent/HK1156313A1/xx not_active IP Right Cessation
-
2012
- 2012-07-05 HR HRP20120549AT patent/HRP20120549T1/hr unknown
- 2012-09-13 CY CY20121100841T patent/CY1113112T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR071530A1 (es) | Derivados de tienopiridonas como activadores de proteina quinasa activa-dos por amp (ampk) | |
| DOP2019000083A (es) | COMPUESTOS DE BENZO[b]TIOFENO COMO AGONISTAS DE STING | |
| AR072148A1 (es) | Derivados de quinoxalindiona | |
| AR055772A1 (es) | Aza -heterociclos como inhibidores de quinasas, preparacion de los compuestos y medicamento preparado en base al compuesto | |
| AR082414A1 (es) | Carboxamidas azaheterociclicas biciclicas utiles para tratar enfermedades hiperproliferativas e inflamatorias, composiciones farmaceuticas que las contienen y procedimiento para prepararlas | |
| PE20151501A1 (es) | Inhibidores de prmt5 y sus usos | |
| ECSP099056A (es) | Azolilmetiloxiranos, su uso para combatir hongos fitopatógenos, así como productos que los contienen | |
| AR078313A1 (es) | Derivados de piridinil-imidazolona inhibidores de quinasas pi3k,composiciones farmaceuticas que los comprenden, metodo para prepararlos y uso de los mismos en el tratamiento de enfermedades autoinmunes e inflamatorias, entre otras | |
| AR086538A1 (es) | COMPUESTOS PARA REDUCIR LA PRODUCCION DE b-AMILOIDE | |
| CO6331467A2 (es) | Nuevos derivados de imidazo(1,2-a)piridina, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion particularmente como inhibidores de met | |
| AR092289A1 (es) | Derivados de aminoquinazolina y sus sales y metodos de uso | |
| AR085283A1 (es) | Antagonistas de hepcidina a base de sulfonaminoquinolina | |
| AR056986A1 (es) | Aza heterociclos como inhibidores de quinasas. procedimiento de obtencion y composiciones farmaceuticas | |
| AR067506A1 (es) | Derivados de quinazolinamida | |
| ES2569539T3 (es) | Derivados de piperidin-4-il azetidina como inhibidores de JAK1 | |
| CO6331463A2 (es) | Nuevos derivados de triazolo(4,3-a)piridina, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion particularmente como inhibidores de met | |
| AR067646A1 (es) | Ariloxazoles sustituidos y su uso | |
| AR075892A1 (es) | Derivados de benzotiadiazepinas, su procedimiento de preparacion y composiciones farmaceuticas que los contienen | |
| AR061610A1 (es) | Azolilmetiloxiranos, su uso para combatir hongos fitopatogenos, asi como productos que los contienen | |
| AR082722A1 (es) | Derivados de pirimidina | |
| AR064508A1 (es) | Azolilmetiloxiranos su uso para combatir hongos fitopatogenos asi como productos que contienen los mismos | |
| MA32460B1 (fr) | Derives d'azacarbolines, leur preparation et leur utilisation therapeutique en tant qu'inhibiteurs de kinases | |
| BR112014026266A2 (pt) | derivado de quinazolidinadiona | |
| AR054877A1 (es) | Derivados de ciclobutano-3-eno-1,2-diona como inhibidores,reguladores y/o moduladores de quinasas | |
| NI201100020A (es) | NUEVOS DERIVADOS DE IMIDAZO[1,2-a] PIRIMIDINA, SU PROCEDIMIENTO DE PREPARACION, SU APLICACIÓN COMO MEDICAMENTOS, COMPOSICIONES FARMACEUTICAS Y NUEVA UTILIZACIÓN PARTICULARMENTE COMO INHIBIDOR DE MET. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal | ||
| FG | Grant, registration |